Why is Amerise BioScie falling/rising?

As of 12-Sep, Amerise Biosciences Ltd is experiencing a decline in its stock price, currently at 0.72, which reflects a decrease of 0.03 or 4.0%. The stock has underperformed its sector by 5.2% today, and its delivery volume has significantly decreased by 33.47% compared to the 5-day average, indicating falling investor participation. Over the past week, the stock has shown a modest gain of 2.86%, but it has struggled in the longer term, with a year-to-date decline of 40.50% and a 1-month decrease of 1.37%. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.
In the broader market context, the stock's short-term performance over the past week has outpaced the Sensex, which gained 1.48% during the same period. However, the longer-term returns reveal a stark contrast, as Amerise Biosciences has significantly underperformed the benchmark, with a year-to-date decline of 40.50% compared to the Sensex's gain of 4.82%. This disparity highlights the challenges faced by the company in maintaining investor confidence and market performance relative to broader market trends.